Skip to Main Content
TRC_PLH
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Diabetes Drugs
    • Do Not Crush List
    • IV Fluid Safety
    • New Drugs
    • Opioid Dosing
    • Vancomycin Dosing
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Hospital Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Psychiatry
  4. Substance Use Disorder
  5. Treatment

Treatment

  • ADHD (38)
  • Agitation (2)
  • Anxiety (26)
  • Bipolar Disorder (8)
  • Depression (149)
  • Mental Health (27)
  • Resources (132)
  • Schizophrenia (40)
  • Sleep Disorders (56)
  • Substance Use Disorder (170)
    • Alcohol (4)
    • Drug Testing (7)
    • Drugs of Abuse (139)
    • Treatment (51)
31 - 45 of 51 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Other: Naloxone for Overdose Prevention (Intramuscular) June 2018
PL Voices: Expanding Access to Naloxone June 2018
Other: Naloxone for Overdose Prevention (Intranasal) June 2018
Article: Make Sure Patients on Sublocade Have an Active Order in the EHR March 2018
Article: Know How to Treat Acute Pain in Patients Taking Meds for Opioid Dependence January 2018
Article: Promote Safe Opioid Use in Pregnant Women November 2017
Archive: Conversation Starter: Chronic Opioid Use November 2017
Article: Expect Less Focus on Psychiatric Effects With Varenicline February 2017
PL Voices: Psychiatric Effects of Varenicline and Bupropion in Smoking Cessation February 2017
Other: Chantix and Zyban Mental Health Side Effects Revised February 2017
Other: Chantix and Zyban Mental Health Side Effects Revised February 2017
Article: Help Patients Safely Continue Their Buprenorphine While in the Hospital January 2017
Article: Expect to Use Higher Opioid Doses to Treat Acute Pain in Probuphine Patients August 2016
Other: Preparing and Prescribing Naloxone Rescue Kits January 2016
Article: Don't Rely on Pentoxifylline for Alcoholic Hepatitis July 2015
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved